Navigation Links
John Theurer Cancer Center brings leading experts for its Ninth Annual Neuro-Oncology Symposium
Date:5/9/2013

Hackensack NJ (May 9, 2013) - John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will host its Ninth Annual Neuro-Oncology Symposium on Friday, May 17th from 8:00am-1:00pm. Experts from MD Anderson, Memorial Sloan Kettering Cancer Center, Penn State Milton S. Hershey Medical Center, and the Cleveland Clinic will present advances in multidisciplinary care for cancers of the central nervous system.

"Our guest speakers are among the nation's leaders in neuro-oncology," said Samuel Goldlust, M.D., Co-Chief of the Brain and Spine Institute at John Theurer Cancer Center. "They will present their perspectives on the latest neurosurgical and medical treatment options and those on the horizon."

This program is intended for all healthcare providers who care for patients with central nervous system (CNS) cancers. At the conclusion of the program participants will be able to identify current standards of care, describe benchmark data that led to current treatment paradigms, and review recent advances in multidisciplinary care and the potential impact on survival and quality of life.

"This is an opportunity for healthcare professionals in the tristate area involved in the treatment of CNS cancers to learn about advances in research that shape the way we care for patients. " said George Kaptain, M.D., Co-Chief of the Brain and Spine Institute.

Featured speakers and their presentations include:

  • John DeGroot, M.D., Associate Professor, Department of Neuro-Oncology, University of Texas, M.D. Anderson Cancer Center: Anti-Angiogenic Therapy: Efficacy and Mechanisms of Resistance
  • Michael J. Glantz, M.D., Professor Neurosurgery, Medicine and Neurology, Penn State Milton S. Hershey Medical Center: Neoplastic Meningitis: How Can We Stop Snatching Defeat From The Jaws of Victory?
  • Jason T. Huse, M.D., Ph.D., Assistant Attending, Department of Pathology, Memorial Sloan-Kettering Cancer Center: The Emerging Molecular Foundations of Diffuse Gliomas
  • Michael Vogelbaum, M.D., Ph.D., Associate Director, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic Foundation: Surgery for Gliomas: How Far Should We Go?

"It's an exciting time for neuro-oncology at our Brain and Spine Institute," said Chief Emeritus Mark S. Pascal, M.D. "Recently we have seen tremendous programmatic growth, including in our Gamma Knife radiosurgery center, robust clinical trial program, and dedicated support services for neuro-oncology patients."

The conference will be held at John Theurer Cancer Center, 92 Second Street, Hackensack, NJ 07601. HackensackUMC designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credit(s), physicians should only claim credits commensurate with the extent of their participation in the activity. This conference is complimentary but advanced registration is required. To register or for more information, please contact Maryann V. Lederhilger at 551-996-1162 or mlederhilger@HackensackUMC.org.

"Oncology is moving at an accelerated pace," said Andre Goy, M.D., M.S., Chairman and Director, Chief of Lymphoma, John Theurer Cancer Center and Chief Science Officer and Director of Research and Innovation at Regional Cancer Care Associates. "We believe it is more important than ever to help physicians and healthcare professional stay up to date with the latest research and treatment best practices."

"John Theurer Cancer Center is committed to helping healthcare professionals gain access to, and knowledge of, the latest advancements in cancer care, and we are proud to offer continuing education programs like the neuro-oncology symposium to help fulfill this goal," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer, Professor, and Vice President of Cancer Services and President of Regional Cancer Care Associates.


'/>"/>

Contact: Amy Leahing
aleahing@p4strategy.com
646-476-3845
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. John Theurer Cancer Center hosts first Womens Oncology Conference
2. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
3. John Theurer Cancer Center researchers shed light on new multiple myeloma therapy
4. Experts from John Theurer Cancer Center to participate in the AAMDSIF Patient and Family Conference
5. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
6. Research finds identifies social needs of young people with cancer
7. Popular diabetes drug does not improve survival rates after cancer: Study
8. Your immune system: On surveillance in the war against cancer
9. Fun and friends help ease the pain of breast cancer
10. Missouri Man Alleges Five Years of Actos Use Caused his Bladder Cancer; Parker Waichman LLP Files Lawsuit on Victim’s Behalf
11. Just How Might Exercise Lower Breast Cancer Risk?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel ... the Food Bank of Eastern Michigan last Friday in order to aid in the ... the Midwest to include a facility located in Clio, only 15 miles away from ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand Interpreting ... Healthcare, recently partnered with Heart City Health Center to improve access ... years, Heart City Health Center has provided the Elkhart community with access to ...
(Date:2/10/2016)... , ... February 10, 2016 , ... 10 Best ... There were three leading bottled water brand owners that topped the list as a ... connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch water ...
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors ... the latest addition to its growing list of Partner Firms. S.S. Nesbitt ... from Orlando to Huntsville and in between. , Harnessing the experience and insights ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged to ... shows that the Goal Attainment Scale (GAS) captures 20% more change in outcomes ... more about the Goal Attainment Scale, Education Resources Inc. is offering a course ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ... reverse split of its issued and outstanding shares of ... Thursday, February 11, 2016. The Company,s common stock will ... 76303T308 and temporary ticker symbol "RCHAD". After 20 trading ... ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
(Date:2/10/2016)... , Feb. 10, 2016  The ALS Association, in partnership ... Grand Challenge to generate a biomarker to track TDP43 aggregation. ... up to a $1 million investment. ... disease that affects nerve cells in the brain and the ... initiate and control muscle movement, which often leads to total ...
Breaking Medicine Technology: